Oxford BioDynamics (OXBOF) Financial Statements

9 Followers

Oxford BioDynamics Financial Overview

Oxford BioDynamics's market cap is currently $21.78M. The company's EPS TTM is $-0.004; its P/E ratio is -0.30; Oxford BioDynamics is scheduled to report earnings on June 30, 2026, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.

	Sep 25	Sep 24	Sep 23	Sep 22	Sep 21
Income Statement
Total Revenue	£ 1.09M	£ 636.00K	£ 510.00K	£ 154.00K	£ 341.00K
Gross Profit	£ -6.15M	£ 289.00K	£ 266.00K	£ 116.00K	£ -557.00K
Operating Income	£ -10.66M	£ -12.89M	£ -11.03M	£ -8.60M	£ -7.51M
EBITDA	£ -9.80M	£ -10.27M	£ -9.84M	£ -6.16M	£ -6.43M
Net Income	£ -11.15M	£ -11.57M	£ -10.83M	£ -6.71M	£ -6.68M
Balance Sheet
Cash & Short-Term Investments	£ 1.39M	£ 2.83M	£ 5.25M	£ 999.00K	£ 4.34M
Total Assets	£ 8.09M	£ 12.11M	£ 16.13M	£ 11.34M	£ 15.38M
Total Debt	£ 5.11M	£ 5.74M	£ 6.44M	£ 6.14M	£ 6.59M
Net Debt	£ 3.72M	£ 3.91M	£ 1.19M	£ 5.16M	£ 4.41M
Total Liabilities	£ 6.97M	£ 7.75M	£ 10.07M	£ 8.76M	£ 8.69M
Stockholders' Equity	£ 1.12M	£ 4.36M	£ 6.05M	£ 2.59M	£ 6.68M
Cash Flow
Free Cash Flow	£ -7.73M	£ -10.77M	£ -9.01M	£ -6.08M	£ -9.01M
Operating Cash Flow	£ -7.71M	£ -10.17M	£ -8.29M	£ -5.18M	£ -5.92M
Investing Cash Flow	£ 756.00K	£ -1.49M	£ -691.00K	£ 1.25M	£ 2.83M
Financing Cash Flow	£ 6.52M	£ 8.25M	£ 13.42M	£ 2.56M	£ -804.00K

Currency in GBP

Oxford BioDynamics Earnings and Revenue History

Income Statement >

Oxford BioDynamics Debt to Assets

Balance Sheet >

Oxford BioDynamics Cash Flow

Cash Flow >

Oxford BioDynamics Forecast EPS vs Actual EPS

Earnings >